Leadership Overview
Edwards Lifesciences has 6 executives leading key functions including finance, sales, supply chain, surgical structural heart, strategy, and president.
Driven by a commitment to patient well-being, Edwards Lifesciences is dedicated to advancing medical technologies for structural heart disease and critical care monitoring, aiming to deliver life-changing therapies and improve global patient outcomes.
Driven by a commitment to patient well-being, Edwards Lifesciences is dedicated to advancing medical technologies for structural heart disease and critical care monitoring, aiming to deliver life-changing therapies and improve global patient outcomes.
Leadership Roles at Edwards Lifesciences
Doretta Mistras - Chief Financial Officer
Doretta Mistras, the Chief Financial Officer at Edwards Lifesciences, directs all financial operations and strategic fiscal planning. Overseeing budgeting, forecasting, and financial reporting, Mistras ensures robust financial health and supports the company's growth initiatives. This leadership position involves managing capital allocation, investor relations, and risk management to safeguard company assets and maximize shareholder value. Doretta Mistras drives financial strategies that align with the company's mission of improving patient outcomes through innovative medical technologies. The Chief Financial Officer's oversight extends to optimizing financial performance across global markets, ensuring compliance with regulatory standards, and fostering a culture of fiscal responsibility throughout the organization. This role is critical in funding research and development for life-changing therapies in structural heart disease and critical care monitoring.
Miyuki Ogushi - Representative Executive Officer and President and
Miyuki Ogushi, the Representative Executive Officer and President and at Edwards Lifesciences, holds a pivotal leadership position overseeing broad operational and strategic mandates. This executive directs key business functions, driving the company's mission to deliver life-changing therapies for structural heart disease and critical care monitoring. Ogushi's responsibilities encompass ensuring global operational efficiency and fostering innovation across all divisions. Miyuki Ogushi champions the company's commitment to advancing patient care and improving cardiovascular health worldwide. The Representative Executive Officer and President and collaborates with the executive team to set corporate direction and execute strategies that enhance market leadership and patient impact. This role is central to guiding Edwards Lifesciences' continued growth and its dedication to medical technology advancements.
Veronica Shin - Chief Sales Officer (CSO)
Veronica Shin, the Chief Sales Officer (CSO) at Edwards Lifesciences, spearheads all global sales strategies and execution. Directing the sales force across diverse markets, Shin focuses on expanding market penetration for structural heart disease solutions and critical care monitoring technologies. This executive role involves building strong relationships with healthcare providers and distributors to ensure widespread access to life-changing therapies. Veronica Shin drives revenue growth by optimizing sales processes and fostering a high-performance sales culture. The Chief Sales Officer (CSO) collaborates closely with marketing and product development teams to align sales efforts with market needs and company objectives. Veronica Shin's leadership ensures that Edwards Lifesciences' innovative medical technologies reach patients worldwide, directly contributing to improved cardiovascular health outcomes.
Joseph Nuzzolese - Corporate Vice President, Global Supply Chain & Quality
Joseph Nuzzolese, the Corporate Vice President, Global Supply Chain & Quality at Edwards Lifesciences, manages the end-to-end supply chain operations and ensures stringent quality standards. Overseeing procurement, logistics, and manufacturing support, Nuzzolese guarantees the efficient and reliable delivery of medical devices globally. This critical role involves maintaining the integrity and quality of products, from raw material sourcing to final distribution, supporting the company's mission to provide life-changing therapies. Joseph Nuzzolese drives operational excellence and continuous improvement within the supply chain and quality assurance functions. The Corporate Vice President, Global Supply Chain & Quality works to enhance resilience and efficiency across all operational facets, ensuring compliance with international regulations and supporting the company's commitment to patient safety and product efficacy in structural heart disease and critical care monitoring.
Daveen Chopra - Corporate Vice President, Surgical Structural Heart
Daveen Chopra, the Corporate Vice President, Surgical Structural Heart at Edwards Lifesciences, leads the strategic direction and commercialization of surgical solutions for structural heart disease. This executive manages product development, market access, and physician engagement for the surgical portfolio. Chopra's leadership focuses on advancing patient care through innovative surgical therapies, ensuring Edwards Lifesciences remains at the forefront of cardiovascular treatment. Daveen Chopra drives the growth and adoption of these critical medical technologies across global markets. The Corporate Vice President, Surgical Structural Heart collaborates with R&D and clinical teams to bring next-generation surgical devices to market, directly impacting patient outcomes and supporting the company's core mission. This role is pivotal in expanding treatment options for patients with complex heart conditions.
Donald Bobo - Corporate Vice President, Strategy & Corporate Development
Donald Bobo, the Corporate Vice President, Strategy & Corporate Development at Edwards Lifesciences, shapes the company's long-term strategic vision and identifies key growth opportunities. Overseeing mergers, acquisitions, and strategic partnerships, Bobo ensures alignment with the company's mission to improve patient outcomes through innovative medical technologies. This leadership position involves rigorous market analysis and evaluation of potential ventures that enhance Edwards Lifesciences' capabilities in structural heart disease and critical care monitoring. Donald Bobo drives strategic initiatives that foster innovation and expand the company's global reach. The Corporate Vice President, Strategy & Corporate Development plays a crucial role in portfolio management and resource allocation, positioning the company for sustained success and leadership in the medical technology sector.
Explore Leadership Teams in Manufacturing
Miracle-Ear, a division of Amplifon Group, has been a trusted resource in hearing solutions for over 70 years. Based in Minneapolis, MN, Miracle-Ear specializes in customizable hearing solutions that feature discreet, comfortable products designed to meet each individual's hearing loss needs.
Company Leadership JC
SB
RH
MiMedx Group, Inc., a biopharmaceutical company, develops and markets regenerative biologics utilizing human placental tissue allografts with patent-protected processes for various sectors of healthcare. It processes the human placental tissue utilizing its proprietary PURION Process to produce allografts. The companys proprietary processing methodology employs aseptic processing techniques in addition to terminal sterilization. Its biomaterial platform technologies include AmnioFix and EpiFix that are tissue technologies processed from human amniotic membrane derived from donated placental tissue for homologous applications; OrthoFlo, an amniotic fluid-derived allograft for homologous applications; Physio, a bone grafting material comprising 100% bone tissue with no added carrier; and CollaFix, a technology platform derived from collagen fiber technology designed to mimic the natural composition, structure, and mechanical properties of musculoskeletal tissues to augment their repair. The company also offers EpiCord, an umbilical cord allograft that provides a connective tissue matrix to replace or supplement damaged or inadequate integumental tissue; AmnioCord, an umbilical cord allograft that offers a protective environment for the healing process; and AmnioFill, a cellular tissue matrix allograft that enhances healing. Its products have applications in the areas of wound care, burns, surgery, orthopedics, spine, sports medicine, ophthalmology, and dentistry. The company sells its products through direct sales force, and independent stocking distributors, and third party representatives in the United States, as well as independent distributors internationally. MiMedx Group, Inc. is headquartered in Marietta,...
Company Leadership
DR
DM
WT
ProMedic specializes in the importing and distribution of medical equipment and devices as well as medical gas network supply and installation, being a turnkey project provider for hospitals. Its main objective is to supply and install quality products, sourced from leading manufacturers around the world, that are backed by qualified technical support and after sales service. After 25 years of experience in the medical field, the founders of ProMedic merged together to form ProMedic Group. ProMedic creates value for healthcare providers by shifting their business model into a patient-centered, profitable and innovative model ready to evolve and meet the future challenges of the healthcare industry.
Company Leadership FK
AK
RD
Fisher & Paykel Healthcare, founded in 1971 and headquartered in New Zealand, is a manufacturer of respiratory equipment for the medical industry.
Company Leadership EB
Frequently Asked Questions Regarding Edwards Lifesciences Top Executives and Leadership Team
Unlock more people and company data
